Delivery Order SPE2DR25D2005-SPE2DR26FE7V2
- Not listed
- The Defense Logistics Agency awarded a $1,154.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100-count units) on December 10, 2025, with completion expected by December 11, 2025. This non-set-aside contract represents a competitive procurement action that leverages AmerisourceBergen's existing pharmaceutical supply capabilities within the federal medical supply chain. The delivery location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Premarin 0.3 mg tablets in quantities of 100 units, valued at $2,935.22. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by December 12, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters. This...
- The Defense Logistics Agency awarded a $2,045.53 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Premarin 0.3 mg tablets (100-unit quantity). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 22, 2025. The contract is performed out of AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,614.48 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price contract involves no set-aside designation and represents a competitive award to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Premarin 0.625 mg tablets (100-count units) with a contract ceiling value of $2,928.96. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for ultimate completion by November 6, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,947.08 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg on November 25, 2025, with completion scheduled for November 26, 2025. This non-set-aside contract represents a firm fixed price delivery order under an existing indefinite delivery vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor supporting federal medical procurement needs...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100 count) with a ceiling value of $2,838.39. This non-competitive, firm fixed-price delivery order, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider headquartered in...
- The Defense Logistics Agency (DLA) awarded a $5,016.99 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.45 mg on December 11, 2025, with completion scheduled for December 12, 2025. This firm fixed-price, non-set-aside contract represents a direct delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,014.80 to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100 count) on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The awardee, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, which serves as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $3,539.65 to AmerisourceBergen Drug Corp for the supply of Premarin 0.45 mg tablets (100-count) under a firm fixed-price contract. This non-set-aside delivery order was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7V2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,418.55 to AmerisourceBergen Drug Corp for the supply of Premarin 0.9 mg tablets (100-count units) on December 1, 2025, with an ultimate completion date of December 2, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken. This delivery order represents a small-value transaction executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999.99 million and extending through December 2026. AmerisourceBergen serves as a critical pharmaceutical supplier to the Defense Health Agency and military healthcare systems worldwide, providing an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's track record of competitively awarded federal contracts demonstrates its established capability to meet federal procurement requirements for pharmaceutical products supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 11/30/25 |